Journal profile · Rheumatology
JCR Journal of Clinical Rheumatology
ISSN 1076-1608 · eISSN 1536-7355 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 1995
JCR Journal of Clinical Rheumatology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.83; JCR Q3 (journal website); hybrid open access; median 67 days to acceptance (53 articles, last 24 months); community-reported acceptance: easy; 117 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
JCR Journal of Clinical Rheumatology is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Vasculitis and related conditions, together about 33% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
To assess whether baseline bone mineral density (BMD) influences treatment response and predicts the need for treatment switching in patients with chronic nonbacterial osteomyelitis (CNO).
From the journal's Aims & Scope
Research area (LetPub): Rheumatology
Editor-in-chief Joan von FeldtPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine14.9%
- Systemic Lupus Erythematosus ResearchMedicine10.7%
- Vasculitis and related conditionsMedicine7.4%
- Spondyloarthritis Studies and TreatmentsMedicine6.2%
- Inflammatory Myopathies and DermatomyositisMedicine6.2%
- Systemic Sclerosis and Related DiseasesMedicine5.7%
- Autoimmune and Inflammatory Disorders ResearchMedicine5.6%
- Gout, Hyperuricemia, Uric AcidMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q3 · RHEUMATOLOGY · rank 37/58
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.83LetPub ·
- Impact factor (publisher)
- 1.9Publisher website ·
- CiteScore 2026-06
- 3.6LetPub ·
- SJR 2026-06
- 0.61LetPub ·
- SNIP 2026-06
- 0.69LetPub ·
- h-index
- 46LetPub ·
- h-index
- 75OpenAlex ·
- i10-index
- 1,336OpenAlex ·
- 2-year mean citedness
- 1.19OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 10.63%LetPub ·
Volume
- Articles per year
- 75LetPub ·
Articles by year OpenAlex count · 5,159 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 92 | 10 | 11 |
| 2025 | 117 | 8 | 118 |
| 2024 | 136 | 28 | 280 |
| 2023 | 117 | 16 | 443 |
| 2022 | 116 | 34 | 637 |
| 2021 | 163 | 18 | 963 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
67 daysMedian, submission to acceptance · P25–P75 34 days – 107 days
- Acceptance to online
- median 38 days (53 articles)
- Submission to online
- median 115 days
- Sample
- 53 articles with submission and acceptance dates (264 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1995
- ISSN
- 1076-1608
- Electronic ISSN
- 1536-7355
- Latest issue on the website
- Volume 32, Issue 6 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about JCR Journal of Clinical Rheumatology
What CAS zone is JCR Journal of Clinical Rheumatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, JCR Journal of Clinical Rheumatology is in Zone 4 of Medicine, and in Zone 4 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JCR Journal of Clinical Rheumatology?
The latest impact factor listed by LetPub is 1.83; CiteScore 3.6, h-index 75.
How long does peer review take at JCR Journal of Clinical Rheumatology?
Based on the dates recorded on 53 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 67 days (interquartile range 34–107 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is JCR Journal of Clinical Rheumatology in?
The journal's website gives JCR Q3; by category, RHEUMATOLOGY Q3 (37/58). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index JCR Journal of Clinical Rheumatology?
According to LetPub and DOAJ records, JCR Journal of Clinical Rheumatology is indexed in SCIE and Scopus.
Is JCR Journal of Clinical Rheumatology open access, and what is the APC?
JCR Journal of Clinical Rheumatology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .